Chemotherapy extravasation remains an accidental complication of chemotherapy
administration and may result in serious damage to patients. We review in this article the …

Oncologic emergencies can occur at any time during the course of a malignancy, from the
presenting symptom to end‐stage disease. Although some of these conditions are related to …

OBJECTIVE: To present a clinical update on the prevention, detection, and evidence-based
management of vesicant chemotherapy extravasations. DATA SOURCES: Journal articles …

Aims and objectives To estimate the prevalence of difficult venous access in complex
patients with multimorbidity and to identify associated risk factors. Background In highly …

Objective: Totally implantable venous access devices (portacaths, or “ports”), are widely
used for intermittent central venous access especially for cancer patients. Although ports …

Objective To review the scientific literature related to the safe handling of hazardous drugs
(HDs). Method Critical analysis of works retrieved from MEDLINE, the Cochrane Library …

Aims and Objectives This study aimed to identify risk factors for difficult intravenous
cannulation in relation to characteristics of patients, healthcare providers and devices in …

Anthracyclines (ANTs) are a class of anticancer drugs widely used in oncology. However,
the clinical application of ANTs is limited by their cardiotoxicity. The mechanisms underlying …

Administration of chemotherapy agents can give rise to many safety issues. Extravasation of
a vesicant agent causes tissue blistering and necrosis. This complication of chemotherapy …

Purpose to develop a tool for measuring the difficulty of intravenous line insertion in cancer
patients (DIVA-CP) receiving peripheral chemotherapy. Methods a pilot-validation study …